Transfer of copper between bis(thiosemicarbazone) ligands and intracellular copper-binding proteins. insights into mechanisms of copper uptake and hypoxia selectivity

Bis(thiosemicarbazonato) complexes Cu(II)(Btsc) have attracted interest as promising metallodrugs and, in particular, as copper radiopharmaceuticals. Prototypes Cu(Atsm) and Cu(Gtsm) are membrane-permeable, but their metabolisms in cells are distinctly different: copper that is delivered by Cu(Gtsm) is trapped nonselectively in all cells, whereas copper that is delivered by Cu(Atsm) is retained selectively in hypoxic cells but is "washed out" readily in normal cells. We have studied copper-transfer reactions of these two complexes under various conditions, aiming to model their cellular chemistry. In Me2SO, both complexes exhibited reversible one-electron-reduction processes with Cu(Atsm) being more difficult to reduce than Cu(Gtsm) (E(1/2)'=-0.60 and -0.44 V, respectively, vs AgCl/Ag). Upon introduction of an aqueous buffer into Me2SO, the electrochemical reduction remained chemically reversible for Cu(Atsm) but became irreversible for Cu(Gtsm). However, the estimated difference in their reduction potentials did not change. Chromophoric ligand anions bicinchonate (Bca) and bathocuproine disulfonate (Bcs) were used as Cu(I) indicators to trace the destinations of copper in the reactions and to mimic cellular Cu(I)-binding components ("sinks"). While both BtscH2 ligands have high affinities for Cu(I) (KD in the picomolar range), they cannot compete with Cu(I) sinks such as the copper-binding proteins Atx1 and Ctr1c (or a mimic such as Bcs). In the presence of these proteins, reduction of Cu(II)(Btsc) leads to irreversible transfer of copper to the protein ligands. Endogenous reductants ascorbate and glutathione can reduce Cu(II)(Gtsm) in the presence of such protein ligands but cannot reduce Cu(II)(Atsm). These properties establish a strong correlation between the contrasting cellular retention properties of these complexes and their different reduction potentials. The endogenous reductants in normal cells appear to be able to reduce Cu(II)(Gtsm) but not Cu(II)(Atsm), allowing the latter to be washed out. The more reducing environment of hypoxic cells leads to reduction of Cu(II)(Atsm) and retention of its copper.     

Structural and electronic differences of copper(I) complexes with tris(pyrazolyl)methane and hydrotris(pyrazolyl)borate ligands

Copper(I) complexes with tripodal nitrogen-containing neutral ligands such as tris(3,5-diisopropyl-1-pyrazolyl)methane (L1') and tris(3-tertiary-butyl-5-isopropyl-1-pyrazolyl)methane (L3'), and with corresponding anionic ligands such as hydrotris(3,5-diisopropyl-1-pyrazolyl)borate (L1-) and hydrotris(3-tertiary-butyl-5-isopropyl-1-pyrazolyl)borate (L3-) were synthesized and structurally characterized. Copper(I) complexes [Cu(L1')Cl] (1), [Cu(L1')(OClO3)] (2), [Cu(L1')(NCMe)](PF6) (3a), [Cu(L1')(NCMe)](ClO4) (3b), [Cu(L1')(CO)](PF6) (4a), and [Cu(L1')(CO)](ClO4) (4b) were prepared using the ligand L1'. Copper(I) complexes [Cu(L3')Cl] (5) and [Cu(L3')(NCMe)](PF6) (6) with the ligand L3' were also synthesized. Copper(I) complexes [Cu(L1)(NCMe)] (7) and [Cu(L1)(CO)] (8) were prepared using the anionic ligand L1-. Finally, copper(I) complexes with anionic ligand L3- and acetonitrile (9) and carbon monoxide (10) were synthesized. The complexes obtained were fully characterized by IR, far-IR, 1H NMR, and 13C NMR spectroscopy. The structures of both ligands, L1' and L3', and of complexes 1, 2, 3a, 3b, 4a, 4b, 5, 6, 7, and 10 were determined by X-ray crystallography. The effects of the differences in (a) the fourth ligand and the counteranion, (b) the steric hindrance at the third position of the pyrazolyl rings, and most importantly, (c) the charge of the N3 type ligands, on the structures, spectroscopic properties, and reactivities of the copper(I) complexes are discussed. The observed differences in the reactivities toward O2 of the copper(I) acetonitrile complexes are traced back to differences in the oxidation potentials determined by cyclic voltammetry. A special focus is set on the carbonyl complexes, where the 13C NMR and vibrational data are presented. Density functional theory (DFT) calculations are used to shed light on the differences in CO bonding in the compounds with neutral and anionic N3 ligands. In correlation with the vibrational and electrochemical data of these complexes, it is demonstrated that the C-O stretching vibration is a sensitive probe for the "electron richness" of copper(I) in these compounds.     

beta-diketiminate ligand backbone structural effects on Cu(I)/O(2) reactivity: unique copper-superoxo and bis(mu-oxo) complexes

Copper(I) and -(II) complexes of beta-diketiminate ligands with identical flanking 2,6-diisopropylphenyl groups but divergent backbone substitution patterns were prepared and structurally characterized, and reactions of the Cu(I) species with O(2) at low temperature were explored. Despite being far removed from the coordinated metal ion, the different backbone patterns significantly influence the steric encumbrance exerted by the ligands, as revealed by differences in (a) the structural features of the Cu(I) and Cu(II) complexes and (b) the course of the oxygenation reactions of the Cu(I) compounds. With the less hindered ligand, a rare example of a neutral bis(mu-oxo)dicopper complex was identified on the basis of its diagnostic spectral features (UV-vis, resonance Raman, EPR) and the stoichiometry of O(2) uptake (Cu:O(2) = 2:1). In contrast, oxygenation of the Cu(I) complexes supported by the more hindered ligands yielded novel (superoxo)copper complexes, identified by a Cu:O(2) ratio of 1:1, a lack of an EPR signal, and O-isotope sensitive resonance Raman spectral features (nu(O)(-)(O) = 968 cm(-1), Delta(18)O(2) = 51 cm(-1)). Symmetric coordination of the superoxo ligand is proposed on the basis of Raman data acquired using (16)O(18)O (single peak at 943 cm(-1)).     

Mechanisms controlling the cellular accumulation of copper bis(thiosemicarbazonato) complexes

Copper (Cu) bis(thiosemicarbazonato) metal complexes [Cu(II)(btsc)s] have unique tumor-imaging and treatment properties and more recently have revealed potent neuroprotective actions in animal and cell models of neurodegeneration. However, despite the continued development of Cu(II)(btsc)s as potential therapeutics or diagnostic agents, little is known of the mechanisms involved in cell uptake, subcellular trafficking, and efflux of this family of compounds. Because of their high lipophilicity, it has been assumed that cellular accumulation is through passive diffusion, although this has not been analyzed in detail. The role of efflux pathways in cell homeostasis of the complexes is also largely unknown. In the present study, we investigated the cellular accumulation of the Cu(II)(btsc) complexes Cu(II)(gtsm) and Cu(II)(atsm) in human neuronal (M17) and glial (U87MG) cell lines under a range of conditions. Collectively, the data strongly suggested that Cu(II)(gtsm) and Cu(II)(atsm) may be taken into these cells by combined passive and facilitated (protein-carrier-mediated) mechanisms. This was supported by strong temperature-dependent changes to the uptake of the complexes and the influence of the cell surface protein on Cu accumulation. We found no evidence to support a role for copper-transporter 1 in accumulation of the compounds. Importantly, our findings also demonstrated that Cu from both Cu(II)(gtsm) and Cu(II)(atsm) was rapidly effluxed from the cells through active mechanisms. Whether this was in the form of released ionic Cu or as an intact metal complex is not known. However, this finding highlighted the difficulty of trying to determine the uptake mechanism of metal complexes when efflux is occurring concomitantly. These findings are the first detailed exploration of the cellular accumulation mechanisms of Cu(II)(btsc)s. The study delineates strategies to investigate the uptake and efflux mechanisms of metal complexes in cells, while highlighting specific difficulties and challenges that need to be considered before drawing definitive conclusions.     

Copper Catalysis in Living Systems and In Situ Drug Synthesis

The copper‐catalyzed azide–alkyne cycloaddition (CuAAC) reaction has proven to be a pivotal advance in chemical ligation strategies with applications ranging from polymer fabrication to bioconjugation. However, application in vivo has been limited by the inherent toxicity of the copper catalyst. Herein, we report the application of heterogeneous copper catalysts in azide–alkyne cycloaddition processes in biological systems ranging from cells to zebrafish, with reactions spanning from fluorophore activation to the first reported in situ generation of a triazole‐containing anticancer agent from two benign components, opening up many new avenues of exploration for CuAAC chemistry.     

Recyclable Cu nanoparticle catalyzed azide-alkyne click polymerization

The Cu(I)-catalyzed alkyne-azide cycloaddition(CuAAC) has been developed into a powerful polymerization reaction for the synthesis of new polytriazoles with versatile properties. However, research on recyclable and reusable copper catalyst for click polymerization to meet the requirement of green chemistry was rarely reported. Copper nanoparticles were reported to be capable catalysts for CuAAC. Replacing conventional copper catalyst with copper nanoparticles may realize the recycle and reuse of the copper catalyst in click polymerization. In this paper, copper nanoparticles were prepared and used as an effective catalyst for click polymerization, and soluble polytriazoles with high molecular weights were obtained in excellent yields under optimized reaction conditions. Importantly, the copper nanoparticles can be recycled and reused for up to 11 times for the click polymerization. Moreover, introducing aggregation-induced emission(AIE)-active moiety of tetraphenylethylene into the monomers makes the resultant polymers retain the AIE feature. This work not only provides an efficient recyclable catalytic system for the azide-alkyne click polymerization, but also might inspire polymer chemists to use recyclable copper species to catalyze other polymerizations.     

Modulating catalytic activity of polymer‐based cuAAC “click” reactions

The copper(I)‐catalyzed azide–alkyne cycloaddition (CuAAC) reaction is used to synthesize complex polymer architectures. In this work, we demonstrate the control of this reaction at 25 °C between polystyrene (PSTY) chains through modulating the catalytic activity by varying the combinations of copper source (i.e., Cu(I)Br or copper wire), ligand (PMDETA and/or triazole ligand), and solvent (toluene or DMF). The fastest rate of CuAAC was found using Cu(I)Br/PMDETA ligand in toluene, reaching near full conversion after 15 min at 25 °C. For the same catalysts system, DMF also gave fast rates of “click” (95% conversion in 25 min). Cu(0) wire in toluene gave a conversion of 98% after 600 min, a much higher rate than that observed for the same catalyst system used in DMF. When the PSTY had a chemically bound triazole ring close to the site of reaction, the rate of CuAAC in toluene increased significantly, 97% in 180 min at 25 °C, in agreement with our previously published results. This suggests that rapid rates can be obtained using copper wire and will have direct applications to the synthesis of compound where air, removal of copper, and reuse of the copper catalyst are required. © 2011 Wiley Periodicals, Inc. J Polym Sci Part A: Polym Chem, 2011     

Syntheses of copper(I)cis-1,3,5-tri-iminocyclohexane complexes

Copper(I) complexes of the ligand cis-1,3,5-tris(cinnamylideneamino)cyclohexane (L) have been prepared from a versatile precursor complex, [Cu(I)(L)NCMe]BF4, which incorporates a labile acetonitrile ligand that can be exchanged to give a range of new Cu(L)X complexes (where X = Cl, Br, NO2, SPh). 1H NMR spectra and X-ray structures of the Cl, Br and NO2 complexes show L coordinated in a symmetric fashion about the copper centre. The complexes have been further characterised using UV/Visible spectroscopy and cyclic voltammetry. CuLCl shows an electrochemically reversible Cu(I/II) redox couple at 0.51 V (vs. Ag/AgCl) while the CuLNO2 complex shows an analogous quasi-reversible wave at 0.41 V (vs. Ag/AgCl).     

Helical-chain copper(II) complexes and a cyclic tetranuclear copper(II) complex with single syn-anti carboxylate bridges and ferromagnetic exchange interactions

Tridentate Schiff-base carboxylate-containing ligands, derived from the condensation of 2-imidazolecarboxaldehyde with the amino acids beta-alanine (H2L1) and 2-aminobenzoic acid (H2L5) and the condensation of 2-pyridinecarboxaldehyde with beta-alanine (HL2), D,L-3-aminobutyric acid (HL3), and 4-aminobutyric acid (HL4), react with copper(II) perchlorate to give rise to the helical-chain complexes [[Cu(mu-HL1)(H2O)](ClO4)]n (1), [[Cu(mu-L2)(H2O)](ClO4).2H2O]n (2), and [[Cu(mu-L3)(H2O)](ClO4).2H2O]n (3), the tetranuclear complex [[Cu(mu-L4)(H2O)](ClO4)]4 (4), and the mononuclear complex [Cu(HL5)(H2O)](ClO4).1/2H2O (5). The reaction of copper(II) chloride with H2L1 leads not to a syn-anti carboxylate-bridged compound but to the chloride-bridged dinuclear complex [Cu(HL1)(mu-Cl)]2 (6). The structures of these complexes have been solved by X-ray crystallography. In complexes 1-4, roughly square-pyramidal copper(II) ions are sequentially bridged by syn-anti carboxylate groups. Copper(II) ions exhibit CuN2O3 coordination environments with the three donor atoms of the ligand and one oxygen atom belonging to the carboxylate group of an adjacent molecule occupying the basal positions and an oxygen atom (from a water molecule in the case of compounds 1-3 and from a perchlorate anion in 4) coordinated in the apical position. Therefore, carboxylate groups are mutually cis oriented and each syn-anti carboxylate group bridges two copper(II) ions in basal-basal positions with Cu...Cu distances ranging from 4.541 A for 4 to 5.186 A for 2. In complex 5, the water molecule occupies an equatorial position in the distorted octahedral environment of the copper(II) ion and the Cu-O carboxylate distances in axial positions are very large (>2.78 A). Therefore, this complex can be considered as mononuclear. Complex 6 exhibits a dinuclear parallel planar structure with Ci symmetry. Copper(II) ions display a square-pyramidal coordination geometry (tau = 0.06) for the N2OCl2 donor set, where the basal coordination sites are occupied by one of the bridging chlorine atoms and the three donor atoms of the tridentate ligand and the apical site is occupied by the remaining bridging chlorine atom. Magnetic susceptibility measurements indicate that complexes 1-4 exhibit weak ferromagnetic interactions whereas a weak antiferromagnetic coupling has been established for 6. The magnetic behavior can be satisfactorily explained on the basis of the structural data for these and related complexes.     

Direct nitric oxide detection in aqueous solution by copper(II) fluorescein complexes

A series of FL(n) (n = 1-5) ligands, where FL(n) is a fluorescein modified with a functionalized 8-aminoquinoline group as a copper-binding moiety, were synthesized, and the chemical and photophysical properties of the free ligands and their copper complexes were investigated. UV-visible spectroscopy revealed a 1:1 binding stoichiometry for the Cu(II) complexes of FL(1), FL(3), and FL(5) in pH 7.0 buffered aqueous solutions. The reactions of FL(2) or FL(4) with CuCl(2), however, appear to produce a mixture of 1:1 and 1:2 complexes, as suggested by Job's plots. These binding modes were modeled by the synthesis and X-ray crystal structure determination of Cu(II) complexes of 2-[(quinolin-8-ylamino)methyl]phenol (modL), employed as a surrogate of the FL(n) ligand family. Two kinds of crystals, [Cu(modL)(2)](BF(4))(2) and [Cu(2)(modL')(2)(CH(3)OH)](BF(4))(2) (modL' = 2-[(quinolin-8-ylamino)methyl]phenolate), were obtained. The structures suggest that one oxygen and two nitrogen atoms of the FL(n) ligands most likely bind to Cu(II). Introduction of nitric oxide (NO) to pH 7.0 buffered aqueous solutions of Cu(FL(n)) (1 microM CuCl(2) and 1 microM FL(n)) at 37 degrees C induces an increase in fluorescence. The fluorescence response of Cu(FL(n)) to NO is direct and specific, which is a significant improvement over commercially available small molecule-based probes that are capable of detecting NO only indirectly. The NO-triggered fluorescence increase of Cu(FL(5)) occurs by reduction of Cu(II) to Cu(I) with concomitant dissociation of the N-nitrosated fluorophore ligand from copper. Spectroscopic and product analyses of the reaction of the FL(5) copper complex with NO indicated that the N-nitrosated fluorescein ligand (FL(5)-NO) is the species responsible for fluorescence turn-on. Density functional theory (DFT) calculations of FL(5) versus FL(5)-NO reveal how N-nitrosation of the fluorophore ligand brings about the fluorescence increase. The copper-based probes described in the present work form the basis for real-time detection of nitric oxide production in living cells.     

Dicopper(II) complexes of a new pyrazolate-containing Schiff-base macrocycle and related acyclic ligand

Dicopper(II) complexes of two new 3,5-disubstituted-pyrazole-based ligands, bis(quadridentate) macrocyclic ligand (L1)(2-) and bis(terdentate) acyclic ligand (L2)(-), were synthesised by Schiff base condensation of 3,5-diformylpyrazole and either one equivalent of 1,3-diaminopropane or two equivalents of 2-(2-aminoethyl)pyridine in the presence of one or two equivalents of copper(II) ions, respectively. Copper(II) acetate monohydrate was employed in the synthesis of [Cu(2)(L1)(OAc)(2)], [Cu(2)(L2)(H(2)O)(2)(OAc)(3)] and [Cu(II)(2)(L1)(NCS)(2)]; in the last of these one equivalent of NaNCS per copper(II) ion was also added. The fourth complex, [Cu(2)(L2)(NCS)(2)(DMF)]BF(4), was prepared using copper(II) tetrafluoroborate hexahydrate, along with two equivalents of NaOH and six of NaSCN. All four of these dimetallic complexes have been characterised by single crystal X-ray diffraction: the two macrocyclic complexes are the first such Schiff base complexes to be so characterised. A feature common to all four of the structures is bridging of the two copper(II) centres by the pyrazolate moiety/moieties. The structure determinations show that the coordination mode of the acetate groups in both [Cu(2)(L1)(OAc)(2)].2MeOH.H(2)O and [Cu(2)(L2)(H(2)O)(2)(OAc)(3)] is unidentate as had been tentatively predicted by analysis of the infrared spectra (DeltaOCO of 199 and 208 cm(-1), respectively). The magnetochemical studies of the macrocyclic complexes, over the temperature range 4-300 K, revealed strong antiferromagnetic coupling with J = -169 and -213 cm(-1) for [Cu(2)(L1)(OAc)(2)].2H(2)O and [Cu(II)(2)(L1)(NCS)(2)].DMF respectively. The J values have been discussed in relation to a published correlation involving the CuN(pyrazolate)N(pyrazolate) angles.     

Structural comparison of copper(I) and copper(II) complexes with tris(2-pyridylmethyl)amine ligand

Copper(I) complexes with the tris(2-pyridylmethyl)amine (TPMA) ligand were synthesized and characterized to examine the effect of counteranions (Br(-), ClO(4)(-), and BPh(4)(-)), as well as auxiliary ligands (CH(3)CN, 4,4'-dipyridyl, and PPh(3)) on the molecular structures in both solid state and solution. Partial dissociation of one of the pyridyl arms in TPMA was not observed when small auxiliary ligands such as CH(3)CN or Br(-) were coordinated to copper(I), but was found to occur with larger ones such as PPh(3) or 4,4'-dipyridyl. All complexes were found to adopt a distorted tetrahedral geometry, with the exception of [Cu(I)(TPMA)][BPh(4)], which was found to be trigonal pyramidal because of stabilization via a long cuprophilic interaction with a bond length of 2.8323(12) ?. Copper(II) complexes with the general formula [Cu(II)(TPMA)X][Y] (X = Cl(-), Br(-) and Y = ClO(4)(-), BPh(4)(-)) were also synthesized to examine the effect of different counterions on the geometry of [Cu(II)(TPMA)X](+) cation, and were found to be isostructural with previously reported [Cu(II)(TPMA)X][X] (X = Cl(-) or Br(-)) complexes.     

Synthesis and structural characterisation of (aryl-BIAN)copper(I) complexes and their application as catalysts for the cycloaddition of azides and alkynes

A series of Ar-BIAN-based copper(I) complexes (where Ar-BIAN = bis(aryl)acenaphthenequinonediimine) were synthesised and characterised by (1)H and (13)C NMR spectroscopies, FT-IR spectroscopy, MALDI-TOF-MS spectrometry, cyclic voltammetry and single crystal X-ray diffraction. The bis-chelated complexes of general formula [Cu(Ar-BIAN)(2)]BF(4) (where Ar = C(6)H(5) (1), 4-iPrC(6)H(4) (3), 2-iPrC(6)H(4) (4)) were prepared by reaction of [Cu(NCMe)(4)]BF(4) with two equivalents of the corresponding Ar-BIAN ligands, in dichloromethane, while the mono-chelated complexes of the type [Cu(Ar-BIAN)L(2)]BF(4) (where Ar = 2,6-iPr(2)C(6)H(3), L = PhCN (6); Ar = 4-iPrC(6)H(4), L = PPh(3) (7)) were readily accessible by treatment of [Cu(NCR)(4)]BF(4) (R = Me, Ph) with one equivalent of the corresponding Ar-BIAN ligands in the absence or presence of two equivalents of PPh(3), in the same solvent. The structures of complexes 3, 4, 6 and 7 were obtained by single crystal X-ray diffraction, showing distorted tetrahedral geometries around the copper centres in all cases. The electrochemical studies of these complexes and of the already reported [Cu(2,4,6-Me(3)C(6)H(2)-BIAN)(2)]BF(4) (2) and [Cu(2,6-iPr(2)C(6)H(3)-BIAN)(NCMe)(2)] (5), demonstrated that the bis-chelated complexes 1-4 undergo a reversible one-electron reduction or oxidation processes on copper, while the mono-chelated complexes 5-7 show a partially reversible oxidation and an irreversible reduction feature. Both kinds of (Ar-BIAN)copper(I) complexes are active catalysts for the copper(I)-catalysed azide-alkyne cycloaddition reaction (CuAAC). Complex 7, bearing PPh(3) ligands, exhibits the highest catalytic activity, which is comparable with that of the typical CuSO(4)-sodium ascorbate catalyst system.     

Spectroelectrochemical and computational studies on the mechanism of hypoxia selectivity of copper radiopharmaceuticals

Detailed chemical, spectroelectrochemical and computational studies have been used to investigate the mechanism of hypoxia selectivity of a range of copper radiopharmaceuticals. A revised mechanism involving a delicate balance between cellular uptake, intracellular reduction, reoxidation, protonation and ligand dissociation is proposed. This mechanism accounts for observed differences in the reported cellular uptake and washout of related copper bis(thiosemicarbazonato) complexes. Three copper and zinc complexes have been characterised by X-ray crystallography and the redox chemistry of a series of copper complexes has been investigated by using electronic absorption and EPR spectroelectrochemistry. Time-dependent density functional theory (TD-DFT) calculations have also been used to probe the electronic structures of intermediate species and assign the electronic absorption spectra. DFT calculations also show that one-electron oxidation is ligand-based, leading to the formation of cationic triplet species. In the absence of protons, metal-centred one-electron reduction gives the reduced anionic copper(I) species, [CuIATSM](-), and for the first time it is shown that molecular oxygen can reoxidise this anion to give the neutral, lipophilic parent complexes, which can wash out of cells. The electrochemistry is pH dependent and in the presence of stronger acids both chemical and electrochemical reduction leads to quantitative and rapid dissociation of copper(I) ions from the mono- or diprotonated complexes, [CuIATSMH] and [Cu(I)ATSMH2]+. In addition, a range of protonated intermediate species have been identified at lower acid concentrations. The one-electron reduction potential, rate of reoxidation of the copper(I) anionic species and ease of protonation are dependent on the structure of the ligand, which also governs their observed behaviour in vivo.     

Insights on the binding ability of a new adenine analog: 7-amine-1,2,4-triazolo[1,5-a]pyrimidine. Synthesis and magnetic study of the first copper(II) complexes

Conventional reactions of the new multidentate ligand 7-amine-1,2,4-triazolo[1,5-a]pyrimidine (7atp, 1) with copper(II) salts lead to four novel multidimensional coordination complexes [Cu(7atp)(mal)(H(2)O)(2)]·H(2)O (2), [Cu(2)(μ-7atp)(4)(H(2)O)(2)](ClO(4))(4)·3H(2)O (3), {[Cu(7atp)(2)(μ-ox)]·3H(2)O}(n) (4) and {[Cu(7atp)(2)(μ-suc)]·2H(2)O}(n) (5), where ox(2-), mal(2-) and suc(2-) mean oxalate, malonate and succinate, respectively. In these compounds, the 7atp ligand coordinates monodentately through its atom N3, except for compound 3, which displays N3-N4 coordination mode, giving rise to all to structures with diverse topologies and dimensionality. Compound 2 is a mononuclear entity, 3 consists of dinuclear species, 4 is a zig-zag chain with oxalate as a bridging ligand and 5 is a succinate-bridged mono-dimensional system. All polynuclear metal complexes show antiferromagnetic interactions of with J values ranging from -0.12 to -49.5 cm(-1). The ligand donor capabilities have been estimated by topological analyses of the electron density (QTAIM) and electron localization function (ELF), obtained by DFT calculations. The compounds are the first structurally characterized copper(II) complexes containing the 7atp ligand.     

Pyridazine-bridged copper(I) complexes of bis-bidentate ligands: tetranuclear [2 x 2] grid versus dinuclear side-by-side architectures as a function of ligand substituents

Eight bis-bidentate Schiff-base ligands, derived from 3,6-diformylpyridazine and substituted amino-benzenes, have been prepared. A variety of electron donating/withdrawing and/or sterically demanding/undemanding substituents were employed. Two ligands and five of the six pure copper(I) complexes have been structurally characterised. The sterically unhindered ligand derived from 3,5-difluoroaniline, (m,m-F), was almost completely flat whereas the very sterically hindered ligand derived from trimethylaniline, (o,o,p-Me), was severely twisted. The only dinuclear side-by-side complex obtained, [Cu(I)(2)((o-Ph))(2)](PF(6))(2), was of the ligand derived from 2-aminobiphenyl. All five of the other complexes are believed to be [2 x 2] tetranuclear grid complexes, and this was unequivocally shown to be the case for four of these complexes, [Cu(I)(4)((p-Me))(4)](PF(6))(4), [Cu(I)(4)((o,p-Me))(4)](PF(6))(4), [Cu(I)(4)((m,m-F))(4)](PF(6))(4) and [Cu(I)(4)((m,m-Cl))(4)](PF(6))(4). In all cases the copper(I) centres are substantially distorted from tetrahedral, with the most severe distortion present in the side-by-side complex. In the absence of any special effects, tetracopper(I) [2 x 2] grid architectures are observed to be the favored outcome for 1 : 1 reactions of these bis-bidentate ligands with copper(I) ions. Only when the aromaticity of the ligand was extended by employing a phenyl substituent on the phenyl rings, (o-Ph), did a dicopper(I) side-by-side architecture result. Cyclic voltammetry in acetone revealed that the free ligands did not undergo reduction until potentials below -0.8 V, whereas between three and four reversible one electron reductions were observed, between +0.16 and -0.71 vs. AgCl/Ag, for the tetranuclear copper(I) [2 x 2] grid complexes. The redox potentials observed for these complexes are highly dependent on the nature of the ligand phenyl ring substituent(s). The side-by-side complex had one irreversible reduction process, E(pc)ca.-0.5 V.     

Rational assembly of soluble copper(II) phosphonates: synthesis, structure and magnetism of molecular tetranuclear copper(II) phosphonates

The reactions of the dinuclear copper complexes [Cu(2)(L)(OAc)] [H(3)L = N,N'-(2-hydroxypropane-1,3-diyl)bis(salicylaldimine) or [Cu(2)(L')(OAc)] (H(3)L' = N,N'-(2-hydroxypropane-1,3-diyl)bis(4,5-dimethylsalicylaldimine)] with various phosphonic acids, RPO(3)H(2) (R = t-Bu, Ph, c-C(5)H(9), c-C(6)H(11) or 2,4,6-i-Pr(3)-C(6)H(2)), leads to the replacement of the acetate bridge affording tetranuclear copper(II) phosphonates, [Cu(4)(L)(2)(t-BuPO(3))](CH(3)OH)(2)(C(6)H(6)) (1), [Cu(4)(L)(2)(PhPO(3))(H(2)O)(2)(NMe(2)CHO)](H(2)O)(2) (2), [Cu(4)(L')(2)(C(5)H(9)PO(3))](CH(3)OH)(2) (3), [Cu(4)(L')(2)(C(6)H(11)PO(3)](MeOH)(4)(H(2)O)(2) (4) and [Cu(4)(L')(2)(C(30)H(46)P(2)O(5))](PhCH(3)) (5). The molecular structures of 1-4 reveal that a [RPO(3)](2-) ligand is involved in holding the four copper atoms together by a 4.211 coordination mode. In 5, an in situ formed [(RPO(2))(2)O](4-) ligand bridges two pairs of the dinuclear subunits. Magnetic studies on these complexes reveal that the phosphonate ligand is an effective conduit for magnetic interaction among the four copper centers present; a predominantly antiferromagnetic interaction is observed at low temperatures.     

Copper binding agents acting as copper ionophores lead to caspase inhibition and paraptotic cell death in human cancer cells

We report a quantitative structure-activity relationship study of a new class of pyrazole-pyridine copper complexes that establishes a clear correlation between the ability to promote copper accumulation and cytotoxicity. Intracellular metal accumulation is maximized when ligand lipophilicity allows the complex to rapidly cross the membrane. Copper and ligand follow different uptake kinetics and reach different intracellular equilibrium concentrations. These results support a model in which the ligand acts as an ionophore for the metal ion, cycling between intra- and extracellular compartments as dissociated or complexed entities. When treating cancer cells with structurally unrelated disulfiram and pyrazole-pyridine copper complexes, as well as with inorganic copper, the same morphological and molecular changes were reproduced, indicating that copper overload is responsible for the cytotoxic effects. Copper-based treatments drive sensitive cancer cells toward paraptotic cell death, a process hallmarked by endoplasmic reticulum stress and massive vacuolization in the absence of apoptotic features. A lack of caspase activation, as observed in copper-treated dying cells, is a consequence of metal-mediated inhibition of caspase-3. Thus, copper acts simultaneously as an endoplasmic reticulum (ER) stress inducer and a caspase-3 inhibitor, forcing the cell into caspase-independent paraptotic death. The establishment of a mechanism of action common to different copper binding agents provides a rationale for the exploitation of copper toxicity as an anticancer tool.     

A rapid electrochemical method for determining rate coefficients for copper-catalyzed polymerizations

Copper(I) polyamine complexes have emerged as excellent atom-transfer radical polymerization catalysts. The rate of their reaction with organic halide initiators (the so-called activation step) varies across a broad range, depending on both the structure of the copper complex and the initiator. Herein, we report a new technique for determining the rate of copper-catalyzed activation (k(act)) using cyclic voltammetry coupled with electrochemical simulation. This method is applied to measuring k(act) for one of the most active catalysts, [Cu(I)(Me(6)tren)](+) (Me(6)tren = N,N,N-tris-(2-(dimethylamino)ethyl)amine), in reaction with ethyl bromoisobutyrate.     

Design and spectroscopic characterization of peptide models for the plastocyanin copper-binding loop

The Cu(II)- and Co(II)-binding properties of two peptides, designed on the basis of the active site sequence and structure of the blue copper protein plastocyanin, are explored. Peptide BCP-A, Ac-Trp-(Gly)(3)-Ser-Tyr-Cys-Ser-Pro-His-Gln-Gly-Ala-Gly-Met-(Gly )(3)-His-(Gly)(2)-Lys-CONH(2), conserves the Cu-binding loop of plastocyanin containing three of the four copper ligands and has a flexible (Gly)(3) linker to the second His ligand. Peptide BCP-B, Ac-Trp-(Gly)(3)-Cys-Gly-His-Gly-Val-Pro-Ser-His-Gly-Met-Gly-CONH(2), contains all four blue copper ligands, with two on either side of a beta-turn. Both peptides form 1:1 complexes with Cu(II) through His and Cys ligands. BCP-A, the ligand loop, binds to Cu(II) in a tetrahedrally distorted square plane with axial solvent ligation, while BCP-B-Cu(II) has no tetrahedral distortion in aqueous solution. In methanolic solution, distortion of the square plane is evident for both BCP-Cu(II) complexes. Tetrahedral Co(II) complexes are observed for both peptides in aqueous solution but with 4:2 peptide:Co(II) stoichiometries as estimated by ultracentrifugation. Cu(II) reduction potentials for the aqueous peptide-Cu(II) complexes were measured to be +75 +/- 30 mV vs NHE for BCP-A-Cu(II) and -10 +/- 20 mV vs NHE for BCP-B-Cu(II). The results indicate that the plastocyanin ligand loop can act as a metal-binding site with His and Cys ligands in the absence of the remainder of the folded protein but, by itself, cannot stabilize a type 1 copper site, emphasizing the role of the protein matrix in protecting the Cu binding site from solvent exposure and the Cys from oxidation.